Research Article
Prevalence and Factors Associated with Hydatidiform Mole among Patients Undergoing Uterine Evacuation at Mbarara Regional Referral Hospital
Table 2
Univariate and multivariate logistic regression analyses for factors associated with hydatiform mole.
| | Variable | No CM, n (%) | CM, n (%) | cOR (95% CI) | value | aOR (95% CI) | value |
| | Age categories (years) | | | | 0.0013 | | 0.0053 | | <25 | 66 (98.5) | 1 (1.5) | 1.0 | | 1.0 | | | 25–34 | 65 (97.0) | 2 (3.0) | 2.0 (0.18–22.95) | | 1.5 (0.13–17.43) | | | ≥35 | 33 (80.5) | 8 (19.5) | 16 (1.92–133.36) | | 13.5 (1.46–125.31) | | | Previous abortion | | | | | | 0.051 | | Yes | 37 (84.1) | 7 (15.9) | 6.3 (1.75–22.65) | 0.0041 | 4.3 (1.00–18.57) | | | No | 133 (97.1) | 4 (2.9) | 1.0 | | 1.0 | | | Gestational age | | | | 0.1718 | | 0.042 | | 1st trimester | 75 (97.4) | 2 (2.6) | 1.0 | | 1.0 | | | 2nd trimester | 81 (91.0) | 8 (8.9) | 3.7 (0.76–18.00) | | 6.2 (1.07–36.14) | | | Monthly income status | | | | 0.0243 | | | | <100k | 80 (89.9) | 9 (10.1) | 6.9 (0.85–55.63) | | | | | >100k | 61 (98.4) | 1 (1.6) | 1.0 | | | | | Parity | | | | 0.0916 | | | | Nulliparous | 49 (98.0) | 1 (2.0) | 1.0 | | | | | Primiparous | 31 (96.9) | 1 (3.1) | 1.6 (0.09–26.20) | | | | | Multiparous | 70 (93.3) | 5 (6.7) | 3.5 (0.40–30.89) | | | | | Grand multiparous | 19 (82.6) | 4 (17.4) | 10.3 (1.08–98.31) | | | | | Maternal blood group/rhesus status | | | | | | | | A+ | | | | NA | | | | Yes | 31 (88.6) | 4 (11.4) | 2.6 (0.71–9.30) | | | | | No | 139 (95.2) | 7 (4.8) | 1.0 | | | | | A− | | | | 0.1888 | | | | Yes | 4 (100.0) | 0 (0.0) | NA | | | | | No | 166 (93.8) | 11 (6.2) | 1.0 | | | | | B+ | | | | NA | | | | Yes | 32 (88.9) | 4 (11.1) | 2.5 (0.68–8.93) | | | | | No | 138 (95.2) | 7 (4.8) | 1.0 | | | | | B− | | | | NA | | | | Yes | 2 (100.0) | 0 (0.0) | NA | | | | | No | 168 (93.8) | 11 (6.1) | 1.0 | | | | | AB+ | | | | 0.0867 | | | | Yes | 4 (100.0) | 0 (0.0) | NA | | | | | No | 166 (93.8) | 11 (6.2) | 1.0 | | | | | O+ | | | | NA | | | | Yes | 91 (96.8) | 3 (3.2) | 0.32 (0.83–1.27) | | | | | No | 79 (90.8) | 8 (9.2) | 1.0 | | | | | O− | | | | 0.1590 | | | | Yes | 3 (100.0) | 0 (0.0) | NA | | | | | No | 167 (93.8) | 11 (6.2) | 1.0 | | | | | History of contraceptive use of oral pills | | | | NA | | | | Yes | 19 (86.4) | 3 (13.6) | 2.98 (0.73–12.21) | | | | | No | 151 (94.9) | 8 (5.0) | 1.0 | | | | | Progesterone only pills | | | | 0.8406 | | | | Yes | 6 (100.0) | 0 (0.0) | NA | | | | | No | 164 (93.7) | 11 (6.3) | 1.0 | | | | | Injectaplan | | | | 0.6218 | | | | Yes | 72 (93.5) | 5 (6.5) | 1.1 (0.33–3.86) | | | | | No | 98 (94.2) | 6 (5.8) | 1.0 | | | | | Norplant | | | | NA | | | | Yes | 24 (96.0) | 1 (4.0) | 0.6 (0.74–4.97) | | | | | No | 146 (93.6) | 10 (6.4). | 1.0 | | | | | IUD | | | | NA | | | | Yes | 1 (100.0) | 0 (0.0) | NA | | | | | No | 169 (93) | 11 (6.1) | | | | |
|
|
CM, complete mole; cOR, crude odds ratio; CI, confidence interval; aOR, adjusted odds.
|
